Cygen Consultancy Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 05-12-2024
- Paid Up Capital ₹ 0.10 M
as on 05-12-2024
- Company Age 7 Year, 5 Months
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 1.00 Cr
as on 05-12-2024
- Revenue 562.82%
(FY 2021)
- Profit -21.00%
(FY 2021)
- Ebitda -46.99%
(FY 2021)
- Net Worth 72.66%
(FY 2021)
- Total Assets 595.88%
(FY 2021)
About Cygen Consultancy
The Company is engaged in the Business Outsourcing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.00 Cr.
Laishram Devi and Sumita Palanisamy serve as directors at the Company.
- CIN/LLPIN
U74999MN2017PTC013550
- Company No.
013550
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Jul 2017
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Shillong
Industry
Company Details
- Location
Imphal East, Manipur, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Cygen Consultancy Private Limited offer?
Cygen Consultancy Private Limited offers a wide range of products and services, including Medical Laboratory Instruments, Corona Test Kit.
Who are the key members and board of directors at Cygen Consultancy?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Laishram Devi  | Director | 20-Jul-2017 | Current |
Sumita Palanisamy  | Director | 20-Jul-2017 | Current |
Financial Performance of Cygen Consultancy.
Cygen Consultancy Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 562.82% increase. The company also saw a substantial fall in profitability, with a 21% decrease in profit. The company's net worth Soared by an impressive increase of 72.66%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cygen Consultancy?
In 2021, Cygen Consultancy had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Cygen Healthcare And Research Laboratories Private LimitedActive 3 years 9 months
Laishram Devi and Sumita Palanisamy are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 06 Jul 2022 | ₹1.00 Cr | Open |
How Many Employees Work at Cygen Consultancy?
Unlock and access historical data on people associated with Cygen Consultancy, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cygen Consultancy, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cygen Consultancy's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
